Atsunori Kashiwagi
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 18, 2024
Is glucose-induced hypersecretion of glicentin after the revision surgery using Roux-en-Y gastric bypass related to improved glycemic control due to insulin hypersecretion in a type 2 diabetes patient without diabetes remission after laparoscopic sleeve gastrectomy?Yukako Yamamoto, Osamu Sekine, Jun Ito-Kobayashi
|Dec 19, 2023
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai
|Oct 19, 2023
The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.Yukako Yamamoto, Takeshi Togawa, Osamu Sekine
|Feb 02, 2023
A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels.Masaki Kobayashi, Nobuhiro Maruyama, Yukako Yamamoto
|Dec 14, 2022
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.Atsunori Kashiwagi, Shingo Shoji, Yoshinori Kosakai
|Mar 04, 2022
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan.Atsunori Kashiwagi, Shingo Shoji, Satoshi Onozawa
Pageof 2
